UTHR (United Therapeutics) Change In Inventory : $-49 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is United Therapeutics Change In Inventory?

United Therapeutics's change in inventory for the quarter that ended in Mar. 2025 was $-11 Mil. It means United Therapeutics's inventory increased by $11 Mil from Dec. 2024 to Mar. 2025 .

United Therapeutics's change in inventory for the fiscal year that ended in Dec. 2024 was $-47 Mil. It means United Therapeutics's inventory increased by $47 Mil from Dec. 2023 to Dec. 2024 .

United Therapeutics's Total Inventories for the quarter that ended in Mar. 2025 was $165 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. United Therapeutics's Days Inventory for the quarter that ended in Mar. 2025 was 159.47.

Inventory Turnover measures how fast the company turns over its inventory within a year. United Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.57.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. United Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.20.

United Therapeutics Change In Inventory Historical Data

The historical data trend for United Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Change In Inventory Chart

United Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

10.30

-7.50

-13.40

-13.60

-46.90

United Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-9.30	-14.70	-11.30	-11.60	-11.20

United Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49 Mil.

United Therapeutics (NAS:UTHR) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

United Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	161.65	/	92.5	*	365 / 4
	=	159.47

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

United Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	92.5	/	161.65
	=	0.57

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

United Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	161.65	/	794.4
	=	0.20

United Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Therapeutics Corp (NAS:UTHR) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

UTH:Germany UTH:Germany U2TH34:Brazil

Address

1000 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Executives

Paul A Mahon	officer: EVP & General Counsel
Raymond Dwek	director
Tommy G Thompson	director	7711 CARONDELET, ST. LOUIS MO 63105
Christopher Patusky	director
Michael Benkowitz	officer: President and COO	C/O UNITED THERAPEUTICS CORP, 1040 SPRING STREET, SILVER SPRING MD 20910
Ray Kurzweil	director
Nilda Mesa	director	C/O UNITED THERAPEUTICS CORPORATION, 1040 SPRING STREET, SILVER SPRING MD 20910
Louis W Sullivan	director
Judy D. Olian	director	2000 AVENUE OF THE STARS 12TH FL, LOS ANGELES CA 90067
Richard Giltner	director	C/O UNITED THERAPEUTICS CORPORTION, 1735 CONNECTICUT AVE. NW, WASHINGTON DC 20009
James Edgemond	officer: CFO and Treasurer	1040 SPRING STREET, SILVER SPRING MD 20910
Christopher Causey	director
Martine A Rothblatt	director, officer: Chief Executive Officer
Linda Maxwell	director	1040 SPRING STREET, SILVER SPRING NC 27709
Katherine J Klein	director	STEINBERG HALL-DIETRICH HALL, 3620 LOCUST WALK, PHILADELPHIA PA 19104